Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2022-04-07 Major Shareholding Noti…
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is titled 'Regulation 31(4)- Annual Declar' and contains a tabular disclosure listing names of entities/persons categorized under 'Promoter Group' and 'Promoter' for the financial year ending 31-Mar-2022. Regulation 31(4) typically relates to disclosures of shareholding or promoter group details under securities regulations. The document is short (2107 characters) and is a regulatory disclosure of shareholding or promoter group information rather than a financial report or announcement of voting results. It does not contain financial statements or management commentary. This fits best under Major Shareholding Notification (MRQ), which covers notifications of changes or disclosures in significant share ownership or promoter group details.
2022-04-07 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2022-04-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, this document does not represent a report or announcement but is essentially empty or a placeholder. According to the rules, such documents fall under the fallback category Regulatory Filings (RNS).
2022-04-01 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2022-04-01 English
Closure of trading window
Regulatory Filings
2022-03-30 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-03-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.